Why the study?
Pressure overload in aortic stenosis causes metabolic remodeling associated with energetic and functional impairment, prompting review of cardiac magnetic resonance spectroscopy to assess these changes and guide therapy.
Cardiac magnetic resonance spectroscopy provides a noninvasive method to assess metabolic derangements in aortic stenosis, which may help guide future metabolic therapies.
Answers are grounded in this paper and cite their sources.
MRS supports metabolic phenotyping in severe AS; leaves open whether targeting energetics improves outcomes.
Pressure overload in aortic stenosis (AS) encompasses both structural and metabolic remodeling and increases the risk of decompensation into heart failure. A major component of metabolic derangement in AS is abnormal cardiac substrate use, with down-regulation of fatty acid oxidation, increased reliance on glucose metabolism, and subsequent myocardial lipid accumulation. These changes are associated with energetic and functional cardiac impairment in AS and can be assessed with the use of cardiac magnetic resonance spectroscopy (MRS). Proton MRS allows the assessment of myocardial triglyceride content and creatine concentration. Phosphorous MRS allows noninvasive in vivo quantification of the phosphocreatine-to-adenosine triphosphate ratio, a measure of cardiac energy status that is reduced in patients with severe AS. This review summarizes the changes to cardiac substrate and high-energy phosphorous metabolism and how they affect cardiac function in AS. The authors focus on the role of MRS to assess these metabolic changes, and potentially guide future (cellular) metabolic therapy in AS.
No takes yet. Share an insight, caveat, or question.
Monga et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: